Dr Mike Jones – Managing Director – Impact Minerals (ASX:IPT) is an exploration company listed on the ASX in November 2006. The Company manages extensive tenement holdings (>4,000 km2) within Australia featuring significant potential for high-grade mineral deposits of gold, silver, lead, zinc, copper, nickel and PGM’s.
Copyright 2023 – Finance News Network
29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
23 Jul 2020 - Noxopharm Limited (ASX:NOX) Executive Chairman and CEO Dr Graham Kelly discusses important pre-clinical results for the company's programs.
31 May 2023 - Ron Mitchell, Managing Director of Global Lithium Resources Limited (ASX:GL1), which owns two of the 14 lithium resources in Australia, discusses the price of lithium and progress on the company's projects.
01 May 2023 - James Powell, General Manager - Investor Relations, Corporate Affairs and Sustainability of Rural Funds Management, provides on update for the Rural Funds Group (ASX:RFF).
20 Aug 2021 - TALi Digital Limited (ASX:TD1) Managing Director Glenn Smith introduces the company’s software for the assessment and treatment of childhood attention difficulties and discusses the company's recent agreement with US company Akili.
31 Oct 2023 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company's drug candidates, highlighting promising data from the 2023 ESMO Congress.
20 Nov 2019 - Ausbil Investment Management Chief Investment Officer, Paul Xiradis and Ausbil Head of ESG Research, Måns Carlsson-Sweeny, provide an update on the Ausbil Active Sustainable Equity fund’s performance, talk about what the fund looks for in businesses that fit the description of "sustainable", and discuss how these characteristics provide long-term above-market returns.
28 Aug 2020 - OptiScan Imaging Limited (ASX:OIL) Executive Chairman Darren Lurie provides an update on the company's sales, strategy, and its endomicroscopic imaging technology platform that allows for real-time virtual biopsies via the visualistation of living tissue.
